Regeneron Pharmaceuticals REGN Finance Lease Liability, Current
Finance Lease Liability, Current at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's finance lease liability, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's finance lease liability, current?
- Regeneron Pharmaceuticals (REGN) reported finance lease liability, current of $720M in Q1 2026.
- What does finance lease liability, current mean?
- Finance lease liabilities (current) represent the portion of lease obligations that are due to be paid within the next twelve months. These obligations arise from long-term contracts where the company effectively controls the leased asset. This metric is critical for assessing near-term liquidity and cash flow requirements.